X-linked adrenoleukodystrophy: A cause of primary adrenal insufficiency in males

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

X-linked adrenoleukodystrophy (ALD), char’ acterized by the presence of adrenal insufficiency and demyelination, has recently been recognized to be an important cause of primary adrenal insufficiency in males. This disease has a broad clinical expression with four major presentations. The most common phenotypic group is the severe cerebral form of ALD, which is seen most frequently in childhood. In this form, demyelination advances rapidly over several years and the disease is uniformly fatal. A second common phenotype is the adrenomyeloneuropathy form, which usually has its onset in adulthood and exhibits a slow neurological progression dominated by spastic paraparesis. The third phenotype is isolated Addison disease with no neurological involvement. Asymptomatic and presymptomatic patients comprise the fourth phenotypic group. ALD males can develop adrenal disease long before neurological symptoms arise. The diagnosis of ALD is readily made by measuring plasma levels of saturated very long chain fatty acids, which are elevated in affected patients due to an enzymatic defect in their oxidation. All males with isolated adrenal insufficiency should be tested for ALD because of the potential for therapy and the genetic implications for the family.

Original languageEnglish (US)
Pages (from-to)177-183
Number of pages7
JournalEndocrinologist
Volume2
Issue number3
DOIs
StatePublished - May 1992

Fingerprint

Adrenoleukodystrophy
Addison Disease
Adrenal Insufficiency
Demyelinating Diseases
Spastic Paraparesis
Phenotype
Trout
Genetic Therapy
Fatty Acids

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

X-linked adrenoleukodystrophy : A cause of primary adrenal insufficiency in males. / Rizzo, William B.

In: Endocrinologist, Vol. 2, No. 3, 05.1992, p. 177-183.

Research output: Contribution to journalArticle

@article{503ebb60bd674a409f276309df4e9d3f,
title = "X-linked adrenoleukodystrophy: A cause of primary adrenal insufficiency in males",
abstract = "X-linked adrenoleukodystrophy (ALD), char’ acterized by the presence of adrenal insufficiency and demyelination, has recently been recognized to be an important cause of primary adrenal insufficiency in males. This disease has a broad clinical expression with four major presentations. The most common phenotypic group is the severe cerebral form of ALD, which is seen most frequently in childhood. In this form, demyelination advances rapidly over several years and the disease is uniformly fatal. A second common phenotype is the adrenomyeloneuropathy form, which usually has its onset in adulthood and exhibits a slow neurological progression dominated by spastic paraparesis. The third phenotype is isolated Addison disease with no neurological involvement. Asymptomatic and presymptomatic patients comprise the fourth phenotypic group. ALD males can develop adrenal disease long before neurological symptoms arise. The diagnosis of ALD is readily made by measuring plasma levels of saturated very long chain fatty acids, which are elevated in affected patients due to an enzymatic defect in their oxidation. All males with isolated adrenal insufficiency should be tested for ALD because of the potential for therapy and the genetic implications for the family.",
author = "Rizzo, {William B.}",
year = "1992",
month = "5",
doi = "10.1097/00019616-199205000-00007",
language = "English (US)",
volume = "2",
pages = "177--183",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - X-linked adrenoleukodystrophy

T2 - A cause of primary adrenal insufficiency in males

AU - Rizzo, William B.

PY - 1992/5

Y1 - 1992/5

N2 - X-linked adrenoleukodystrophy (ALD), char’ acterized by the presence of adrenal insufficiency and demyelination, has recently been recognized to be an important cause of primary adrenal insufficiency in males. This disease has a broad clinical expression with four major presentations. The most common phenotypic group is the severe cerebral form of ALD, which is seen most frequently in childhood. In this form, demyelination advances rapidly over several years and the disease is uniformly fatal. A second common phenotype is the adrenomyeloneuropathy form, which usually has its onset in adulthood and exhibits a slow neurological progression dominated by spastic paraparesis. The third phenotype is isolated Addison disease with no neurological involvement. Asymptomatic and presymptomatic patients comprise the fourth phenotypic group. ALD males can develop adrenal disease long before neurological symptoms arise. The diagnosis of ALD is readily made by measuring plasma levels of saturated very long chain fatty acids, which are elevated in affected patients due to an enzymatic defect in their oxidation. All males with isolated adrenal insufficiency should be tested for ALD because of the potential for therapy and the genetic implications for the family.

AB - X-linked adrenoleukodystrophy (ALD), char’ acterized by the presence of adrenal insufficiency and demyelination, has recently been recognized to be an important cause of primary adrenal insufficiency in males. This disease has a broad clinical expression with four major presentations. The most common phenotypic group is the severe cerebral form of ALD, which is seen most frequently in childhood. In this form, demyelination advances rapidly over several years and the disease is uniformly fatal. A second common phenotype is the adrenomyeloneuropathy form, which usually has its onset in adulthood and exhibits a slow neurological progression dominated by spastic paraparesis. The third phenotype is isolated Addison disease with no neurological involvement. Asymptomatic and presymptomatic patients comprise the fourth phenotypic group. ALD males can develop adrenal disease long before neurological symptoms arise. The diagnosis of ALD is readily made by measuring plasma levels of saturated very long chain fatty acids, which are elevated in affected patients due to an enzymatic defect in their oxidation. All males with isolated adrenal insufficiency should be tested for ALD because of the potential for therapy and the genetic implications for the family.

UR - http://www.scopus.com/inward/record.url?scp=0008219210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0008219210&partnerID=8YFLogxK

U2 - 10.1097/00019616-199205000-00007

DO - 10.1097/00019616-199205000-00007

M3 - Article

AN - SCOPUS:0008219210

VL - 2

SP - 177

EP - 183

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 3

ER -